Hepatitis B drug developers chart slow progress forward, just like hep C before it. Read more here.


Welcome to our Liver Cancer Connect Program



Find Clinical Trials Near Me!

hepbfoundation livercancer banner 1

Check out our latest blog post: Highlighting the Relationship between Hepatitis B and Liver Cancer

Read the blog post here. The post highlights a recent project to develop culturally appropriate educational materials for communities heavily impacted by hepatitis B about the link between HBV and liver cancer. Materials for seven of the 12 communities are available now with more coming soon!


Click here to view and download available materials to spread the word about the connection between HBV and liver cancer! 

Check out this video with a liver cancer survivor on Closing the Care Gap!

This is a clinical trials education video for people who are considering participation in a trial. The video explains and answers common questions about the types of clinical trials, how they are conducted, and factors to think about when deciding whether or not to participate in a trial. The video also features actual patients who share their reasons and decisions about participating in cancer clinical trials.

This panel discussion features someone with lived experience of liver cancer and his wife in conversation with researchers and patient advocates. The discussion highlights what is missing in order to improve the lives of people diagnosed with HCC. Check it out today! 

webinar series

View our free webinars to learn about liver cancer treatment, clinical trials, and support services. Webinars are presented in collaboration with Blue Faery: The Adrienne Wilson Liver Cancer Association.

newly diagnosed

Liver Cancer Connect is a dedicated program of the Hepatitis B Foundation that was created to provide individuals and families with the information and support they need when facing the challenge of primary liver cancer. Although this is a serious diagnosis, there is good reason to have hope because of the many advances made in the early detection, management and treatment of liver cancer.

GALAD Score Calculator

This is a quick tool that can diagnose HCC based on serum biomarkers in patients with chronic liver disease (CLD) - check it out today!

GALAD Model for Hepatocellular Carcinoma (HCC)

Cancer Support Community Book

This short book outlines the basics of liver cancer diagnosis, management, and supportive measures for those affected. Read the book for free here


In the News

Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients

Incidence of Etiology-specific Hepatocellular Carcinoma: diverging trends and significant heterogeneity by race and ethnicity

Management of Hepatocellular Carcinoma

NCCN 2023 Liver Cancer Guidelines for Patients

Understanding Cancer Prognosis

Gene mutations linked to drug-resistant liver cancer

Complementary and Alternative Medicine

BAIAP2L2 is a Novel Prognostic Biomarker Related to Migration and Invasion of HCC and Associated with Cuprotosis

Advancing the Care of Advanced HCC – A Hepatologist’s Perspective

Novel Use of Artificial Intelligence Shows Promise to Improve HCC Detection

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection

Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study

Get Connected

square facebook 512Twitter icon horizontal2